Breakout Sessions: Day 1
-
Session A: Early Diagnosis and Clinical Phenotyping
Identify key diagnostic tools (ECG, MRI, biomarkers) and propose standardized use in clinical and research settings.
-
Session B: Anticoagulation and Embolic Event Prevention
Evaluate current evidence and define best practices for anticoagulation across stages of CCC.
-
Session C: Defining ICD Criteria in Chagas Cardiomyopathy
Determine relevant risk factors and propose criteria for primary and secondary prevention with defibrillators.
-
Session D: Antiparasitic Treatment in Chronic Cardiomyopathy
Discuss data gaps and feasibility of clinical trials for antiparasitic treatment in patients with established CCC.